We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Impact of silencing eEF2K expression on the malignant properties of chordoma.
- Authors
Aydemir, Esra; Tüysüz, Emre Can; Bayrak, Ömer Faruk; Tecimel, Didem; Hızlı-Deniz, Ayşen Aslı; Şahin, Fikrettin
- Abstract
Background: Eukaryotic elongation factor 2 kinase (eukaryotic elongation factor 2 kinase, eEF2K) is a calcium calmodulin dependent protein kinase that keeps the highest energy consuming cellular process of protein synthesis under check through negative regulation. eEF2K pauses global protein synthesis rates at the translational elongation step by phosphorylating its only kown substrate elongation factor 2 (eEF2), a unique translocase activity in ekaryotic cells enabling the polypeptide chain elongation. Therefore, eEF2K is thought to preserve cellular energy pools particularly upon acute development of cellular stress conditions such as nutrient deprivation, hypoxia, or infections. Recently, high expression of this enzyme has been associated with poor prognosis in an array of solid tumor types. Therefore, in a growing number of studies tremendous effort is being directed to the development of treatment methods aiming to suppress eEF2K as a novel therapeutic approach in the fight against cancer. Methods: In our study, we aimed to investigate the changes in the tumorigenicity of chordoma cells in presence of gene silencing for eEF2K. Taking a transient gene silencing approach using siRNA particles, eEF2K gene expression was suppressed in chordoma cells. Results: Silencing eEF2K expression was associated with a slight increase in cellular proliferation and a decrease in death rates. Furthermore, no alteration in the sensitivity of chordoma cells to chemotherapy was detected in response to the decrease in eEF2K expression which intriguingly promoted suppression of cell migratory and invasion related properties. Conclusion: Our findings indicate that the loss of eEF2K expression in chordoma cell lines results in the reduction of metastatic capacity.
- Subjects
GENE expression; CHORDOMA; GENE silencing; PROTEIN synthesis; PROTEIN kinases
- Publication
Molecular Biology Reports, 2023, Vol 50, Issue 4, p3011
- ISSN
0301-4851
- Publication type
Article
- DOI
10.1007/s11033-023-08257-z